We are live on ! Find out more
VNRX icon

VolitionRx Ltd
VNRX

24 hedge funds and large institutions have $8.89M invested in VolitionRx Ltd in 2018 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.04% less ownership

Funds ownership: 0.78% → 0.74% (-0.04%)

4% less funds holding

Funds holding: 25 → 24 (-1)

20% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 5

21% less capital invested

Capital invested by funds: $11.2M → $8.89M (-$2.31M)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
24
Holders Change
-1
Holders Change %
-4%
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
3
Increased
4
Reduced
5
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
OC
Oppenheimer & Co
New York
+$82.6K
2
HFM
Hartford Financial Management
Connecticut
+$13.4K
3
Northern Trust
Northern Trust
Illinois
+$9.48K
4
TRCT
Tower Research Capital (TRC)
New York
+$7.42K
5
CPA
Cowen Prime Advisors
New York
+$6.3K

Top Sellers

Rank Fund Capital Flow
1
SC
Skylands Capital
Wisconsin
-$202K
2
LCM
Leisure Capital Management
California
-$176K
3
LIM
Lagoda Investment Management
New York
-$155K
4
Morgan Stanley
Morgan Stanley
New York
-$44.7K
5
SM
Sabby Management
Florida
-$32K
Name Holding Trade Value Shares
Change 		Change in
Stake
LIM
1
Lagoda Investment Management
New York
$6.23M -$155K -3,472 -2%
KCM
2
Knoll Capital Management
Florida
$703K – – –
Vanguard Group
3
Vanguard Group
Pennsylvania
$596K +$894 +20 +0.1%
BCM
4
Bridgeway Capital Management
Texas
$399K – – –
Geode Capital Management
5
Geode Capital Management
Massachusetts
$201K – – –
Morgan Stanley
6
Morgan Stanley
New York
$168K -$44.7K -1,000 -19%
CS
7
Credit Suisse
Switzerland
$130K – – –
Northern Trust
8
Northern Trust
Illinois
$76K +$9.48K +212 +13%
OC
9
Oppenheimer & Co
New York
$74K +$82.6K +1,848 New
SC
10
Skylands Capital
Wisconsin
$62K -$202K -4,512 -75%
GBA
11
Garrison Bradford & Associates
New York
$31K – – –
Royal Bank of Canada
12
Royal Bank of Canada
Ontario, Canada
$28K – – –
Creative Planning
13
Creative Planning
Kansas
$26K – – –
LTFS
14
Ladenburg Thalmann Financial Services
Florida
$25K – – –
BCM
15
BlueCrest Capital Management
Jersey
$22K – – –
Bank of New York Mellon
16
Bank of New York Mellon
New York
$21K -$14.3K -320 -38%
AG
17
Advisor Group
Arizona
$20K – – –
Bessemer Group
18
Bessemer Group
New Jersey
$20K – – –
RE
19
RBC Europe
United Kingdom
$13.2K – – –
HFM
20
Hartford Financial Management
Connecticut
$12K +$13.4K +300 New
BlackRock
21
BlackRock
New York
$11K +$805 +18 +7%
TRCT
22
Tower Research Capital (TRC)
New York
$8K +$7.42K +166 +553%
CPA
23
Cowen Prime Advisors
New York
$6K +$6.3K +141 New
UBS Group
24
UBS Group
Switzerland
$4K -$6.66K -149 -60%
LCM
25
Leisure Capital Management
California
– -$176K -3,674 Closed
1
2

VNRX Hedge Fund Activity: Q2 2018 in Review

24 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q2 2018, worth a combined $8.89M — down 21% from $11.2M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of VNRX and 3 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 4 added.

The largest buyer was Oppenheimer & Co, opening a new position worth an estimated $82.6K. The largest seller was Skylands Capital, cutting an estimated $202K.

  • 24 institutional investors held VolitionRx Ltd (VNRX) as of Q2 2018, down from 25 in Q1 2018.
  • Funds reported $8.89M of VolitionRx Ltd stock for Q2 2018, down 21% quarter-over-quarter.
  • 3 funds opened new VolitionRx Ltd positions in Q2 2018 and 4 closed out, a net change of -1 holder.
  • The largest VolitionRx Ltd buyer in Q2 2018 was Oppenheimer & Co, an estimated $82.6K added.
  • The largest VolitionRx Ltd seller in Q2 2018 was Skylands Capital, an estimated $202K sold.

Based on aggregated 13F filings for Q2 2018.